| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000012891 |
| Receipt No. | R000015063 |
| Official scientific title of the study | Action investigation of carnitine in patients with anorexia nervosa |
| Date of disclosure of the study information | 2014/01/20 |
| Last modified on | 2018/01/21 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | Action investigation of carnitine in patients with anorexia nervosa | |
| Title of the study (Brief title) | CAN | |
| Region |
|
|
| Condition | |||
| Condition | Anorexia Nervosa | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | *To test blood carnitine levels in patients with anorexia nervosa
*To assess the correlation of carnitine and the psychiatric manifestation in patients with anorexia nervosa |
| Basic objectives2 | Pharmacokinetics |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Phase I,II |
| Assessment | |
| Primary outcomes | The body weight, blood carnitine levels, Symptom Rating Scale for Eating Disorders, General Health Questionnaire, Beck`s Depression Inventory-Second Ed, State-Trait Anxiety Inventory, Child Behavior Checklist, Global Assessment of Functioning, NIMH Global Obsessive-Compulsive Scale at start of therapy and finish of therapy, BMI exceeds 16. |
| Key secondary outcomes | Nutritional Status; ALB, Pre ALB, RBP
Liver Function; AST, ALT, gamma GTP Renal Funciton; Creatinine, BUN |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients with anorexia nervosa admitted to the department of psychiatry of Shiga University of Medical Science Hospital | |||
| Key exclusion criteria | *Arbitrary Hospitalization
When the patient or the protector does not agree to study *Involuntary Hospitalization When the protector does not agree to study |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Takahiko Inagaki |
| Organization | Shiga University of Medical Science |
| Division name | Department of Community Psychiatric Medicine |
| Address | Seta Tsukinowa-cho, Otsu City, Shiga, JAPNA |
| TEL | 077-548-2291 |
| kerosuke@belle.shiga-med.ac.jp | |
| Public contact | |
| Name of contact person | Takahiko Inagaki |
| Organization | Shiga University of Medical Science |
| Division name | Department of Community Psychiatric Medicine |
| Address | Seta Tsukinowa-cho, Otsu City, Shiga, JAPNA |
| TEL | 077-548-2291 |
| Homepage URL | |
| kerosuke@belle.shiga-med.ac.jp | |
| Sponsor | |
| Institute | Department of Community Psychiatric Medicine of Shiga University of Medical Science |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Shiga University of Medical Science |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 滋賀医科大学医学部附属病院(滋賀県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | We assess the weight, blood carnitine levels, nutritional status, liver function, renal function, psychiatric manifestation at start of treatment and finish of treatment,BMI >= 16. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000015063 |